Ahmed Omar Kaseb, MD, discusses the current treatment landscape for patients with hepatocellular carcinoma.
Videos
Benjamin P. Levy, MD, discusses the evolution of liquid biopsies in all solid tumors, especially in non–small cell lung cancer (NSCLC) where they are used routinely.
Advanced Ovarian Cancer
HER2+ BC: Residual Disease After Neoadjuvant Therapy
Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Early HER2+ Breast Cancer
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
2
ctDNA Refines Risk in Neoadjuvant-Resistant Breast Cancer
3
Targeting HER2-Low Breast Cancer: the ARX788 Phase 2 Clinical Trial
4
High Survival Seen with Nogapendekin Alfa Inbakicept in Papillary NMIBC
5